April 3, 2022
Video

ACC 2022: Insights from the CoreValve US Pivotal and SURTAVI Trials: Five-Year Incidence, Timing And Predictors of Hemodynamic Valve Deterioration ff Transcatheter snd Surgical Aortic Bioprostheses

Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected

    05:08

    Serge Korjian and Michael Reardon discuss the five-year insights from the CoreValve US Pivotal and SURTAVI Trials presented at ACC 2022.